Search results
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
We are headquartered in Mumbai with a manufacturing facility at Nashik, Maharashtra, contract manufacturing organisations, regional and sales hubs across India. Contact Us. Life at GSK in India. How we help people thrive. Careers.
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
From quarterly updates to key announcements, here you can access GSK investor-related information.
At a glance. GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore GSK in the US. Learn about our US businesses. Oncology. Leading the way to reimagine improved ways of engaging with people with cancer. Respiratory.
As one of the leading Indian biopharma companies, GSK unites science, technology and talent to get ahead of disease together.
GSK Science in the Summer™ Through our STEM investments, we aim to equitably increase children’s confidence in doing science and pursuing STEM careers. That's why we offer GSK Science in the Summer™, a free, inquiry-based science education program that helps students grow to love science.
Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Jul 3, 2024 · GSK has reached a licensing agreement with mRNA vaccine developer CureVac worth up to €1.4bn to develop its vaccines for flu, Covid-19 and avian flu. The UK drugmaker has an existing ...
